Atlas Trials

Cabotegravir Plus Rilpivirine Long-acting Regimen in the Swiss HIV Cohort Study:Uptake, Outcome, and Risk Factors for Treatment Failures

Clinical trial NCT06405464 · UNKNOWN

Trial details

NCT number
NCT06405464
Sponsor
University of Zurich
Status
UNKNOWN
Study type
OBSERVATIONAL
HIV Infections
Start date
2022-03-01
Primary completion
2025-12-31
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.